Table 2.

Adverse events in subjects on study

Adverse event
MSC doseTypeGradeaNumber of subjects
PlaceboHypercholes terolemia11
Hyperkalemia11
Elevated aspartate aminotransferase11
400 μgAnemia11
Hypernatremia11
Skin abrasion11
Blurry vision11
Hyperglycemia11
Headache11
Hyperkalemia11
Musculoskeletal pain11
Light headed (during blood draw)11
800 μgDysgeusia11
Urinary frequency11
Hyperkalemia11
Diarrhea11
Sore throat11
Hypercholesterolemia11
Hyperglycemia11
Leukopenia11
1,200 μgSore throat11
Bronchospasm11
Hypernatremia11
Hyperglycemia11
Headache11
  • aNCI CTC version 3.0.